The effectiveness of the Pfizer / BioNTech vaccine against SARS-CoV-2 infection fell to 39% between June 20 and July 17 in Israel, the Ministry of Health announced on Thursday, noting that this finding is recorded. at a time when the most contagious Delta variant is spreading.
This percentage is significantly lower than the 64% that was mentioned from June 6 to July 3 and the 94,3% that was measured from May 2 to June 5.
However, the effectiveness of the US-German consortium in preventing severe forms of COVID-19 is estimated at 91,4% and its effectiveness in preventing hospital admissions is estimated at 88%, according to estimates the Ministry.
Since the start of the immunization campaign in Israel on 20 December 2020, more than 5,75 million people, or 61,6% of the population, have received the first dose of the vaccine, of which 5,28 million and the second.
In the past 24 hours, 1.275 cases of SARS-CoV-2 were diagnosed, bringing the total number of infections to 856.827, while three more patients with COVID-19 succumbed, bringing the death toll from the pandemic to 6.457.
The number of active cases rose to 9.742, the highest level since March 27.
In addition, the number of patients treated in a serious condition increased to 75 (+7).